Literature DB >> 3743629

Presence of IgE suppressor factors in human colostrum.

M Sarfati, Y Vanderbeeken, M Rubio-Trujillo, D Duncan, G Delespesse.   

Abstract

In spite of intensive investigations, the ability of breast feeding to delay and to attenuate atopic diseases in children remains debatable. This study documents a mechanism whereby breast feeding might interfere with the synthesis of IgE by breast-fed infants. Indeed, we show that colostrum contains IgE-binding factors (IgE-BF) capable of suppressing the in vitro synthesis of human IgE. Colostrum obtained from 15 donors was successively depleted of lipids and casein, filtered through Amicon XM50 membrane (mol. mass cut-off 50 kDa) and lyophilized. IgE-BF was demonstrated in such preparations by two different approaches, i.e. a classical rosette inhibition assay and Western blot analysis. In the first instance, lyophilized preparations of colostrum inhibited the binding of IgE-coated bovine erythrocytes to IgE recovered on the surface of RPMI 8866 lymphoblastoid cells. The rosette-inhibiting activity could be absorbed on IgE- but not on IgG-Sepharose 4B and it could be recovered in the eluate of IgE-Sepharose 4B. The molecular mass of IgE-BF was comprised between 10 to 20 kDa as estimated by gel filtration through a calibrated Sephadex G-75 column. After fractionation on 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transfer to nitrocellulose membrane, colostrum displayed one band of 14 kDa and reacted with radiolabeled IgE but not with IgG nor IgM. This 14-kDa band could be removed by absorbing colostrum with IgE- but not with IgG-Sepharose 4B. Most importantly, the colostrum IgE-BF suppressed the spontaneous in vitro synthesis of IgE by B lymphocytes derived from allergic donors without altering the production of IgM.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3743629     DOI: 10.1002/eji.1830160822

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  Human IgE biosynthesis in vitro.

Authors:  G Del Prete; E Maggi; S Romagnani; M Ricci
Journal:  Clin Rev Allergy       Date:  1989

Review 2.  Environmental risk factors for atopy.

Authors:  B Björkstén
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

3.  Purification and partial biochemical characterization of IgE-binding factors secreted by a human B lymphoblastoid cell line.

Authors:  M Sarfati; T Nakajima; H Frost; E Kilccherr; G Delespesse
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

4.  In vitro production of IgE-binding factors by human mononuclear cells.

Authors:  G Delespesse; M Sarfati; M Rubio-Trujillo
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

5.  Prevention of atopic disorders.

Authors:  Lata Kumar; Pinki Surana
Journal:  Indian J Pediatr       Date:  2002-03       Impact factor: 1.967

Review 6.  Breastfeeding and health in the Western world.

Authors:  C Campbell
Journal:  Br J Gen Pract       Date:  1996-10       Impact factor: 5.386

7.  Native and recombinant soluble CD23 fragments with IgE suppressive activity.

Authors:  M Sarfati; B Bettler; M Letellier; S Fournier; M Rubio-Trujillo; H Hofstetter; G Delespesse
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

8.  Presence of antigenic determinants common to Fc IgE receptors on human macrophages, T and B lymphocytes and IgE-binding factors.

Authors:  M Sarfati; T Nutman; C Fonteyn; G Delespesse
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.